Alaunos Therapeutics (TCRT) Accumulated Expenses (2009 - 2026)
Alaunos Therapeutics' Accumulated Expenses was $132,000 in Q2 2026, down 50.2% from $265,000 a year earlier and down 32.3% from the prior quarter.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Alaunos Therapeutics came in at $200,000, up 13.6% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of -58.7% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $176,000 in FY2024 (-86.9%), $1.34 million in FY2023 (-75.4%), $5.45 million in FY2022 (-10.2%) and $6.08 million in FY2021 (-63.4%).
- Quarterly Accumulated Expenses has moved between $78,000 (Q3 2025) and $13.96 million (Q3 2021) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in 1 of the last eight quarters, with an average decline of 52.6%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q4 2025 (growth of 13.6%); the worst was Q3 2024 (a decline of 88.0%).
- Per Business Quant data, TCRT's Accumulated Expenses in the three quarters before Q2 2026 was $195,000 (Q1 2026), $200,000 (Q4 2025) and $78,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Alaunos Therapeutics | 2.04 Mn | -1.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132,000.00 |
| Mar 31, 2026 | 195,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 231,000.00 |
| Dec 31, 2024 | 176,000.00 |
| Sep 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 542,000.00 |
| Mar 31, 2024 | 643,000.00 |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 3.07 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 4.12 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Sep 30, 2022 | 7.68 Mn |
| Jun 30, 2022 | 5.73 Mn |
| Mar 31, 2022 | 5.89 Mn |
| Dec 31, 2021 | 6.08 Mn |
| Sep 30, 2021 | 13.96 Mn |
API Access
Alaunos Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();